304 related articles for article (PubMed ID: 26851971)
1. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
You YP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
[TBL] [Abstract][Full Text] [Related]
2. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
Lu HT; Zhao JG; Li MH; Li YD
Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin Gallate Extends Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment for Brain Ischemic Stroke: A Randomized Double-Blind and Placebo-Controlled Trial.
Wang XH; You YP
Clin Neuropharmacol; 2017; 40(1):24-28. PubMed ID: 27941526
[TBL] [Abstract][Full Text] [Related]
4. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
[TBL] [Abstract][Full Text] [Related]
6. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
7. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
8. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
[TBL] [Abstract][Full Text] [Related]
9. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
10. The functional effect of epigallocatechin gallate on ischemic stroke in rats.
Lim SH; Kim HS; Kim YK; Kim TM; Im S; Chung ME; Hong BY; Ko YJ; Kim HW; Lee JI
Acta Neurobiol Exp (Wars); 2010; 70(1):40-6. PubMed ID: 20407485
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of liposomal fasudil and tissue plasminogen activator ameliorated ischemic brain damage in occlusion model rats prepared by photochemically induced thrombosis.
Fukuta T; Yanagida Y; Asai T; Oku N
Biochem Biophys Res Commun; 2018 Jan; 495(1):873-877. PubMed ID: 29162447
[TBL] [Abstract][Full Text] [Related]
12. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
13. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
14. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
Maeda M; Furuichi Y; Ueyama N; Moriguchi A; Satoh N; Matsuoka N; Goto T; Yanagihara T
J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659
[TBL] [Abstract][Full Text] [Related]
15. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
[TBL] [Abstract][Full Text] [Related]
16. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
17. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Romanos E; Planas AM; Amaro S; Chamorro A
J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
[TBL] [Abstract][Full Text] [Related]
18. Hemorrhagic profile of the fibrinolytic alfimeprase after ischemia and reperfusion.
Lu A; Kurosawa Y; Luskey K; Pyne-Geithman G; Caudell D; Clark J
Neurol Res; 2009 Mar; 31(2):209-14. PubMed ID: 19298764
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
20. Combination of Ligusticum chuanxiong and Radix Paeoniae ameliorate focal cerebral ischemic in MCAO rats via endoplasmic reticulum stress-dependent apoptotic signaling pathway.
Gu J; Chen J; Yang N; Hou X; Wang J; Tan X; Feng L; Jia X
J Ethnopharmacol; 2016 Jul; 187():313-24. PubMed ID: 27108052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
